SHOCKING: Ovarian cancer | Mind Blowing Facts

Can removing your fallopian tubes really reduce your risk of ovarian cancer?

Ovarian cancer has a particularly poor survival rate. Only one in two women will live five years beyond their diagnosis.

The Conversation · Sep 7

Survival Gaps in Ovarian Cancer Track with Neighborhood Conditions, Pointing Toward Treatment Access

Women with ovarian cancer in highly vulnerable neighborhoods faced 20% higher mortality in a new study. Researchers point toward care access.

Medical Daily · Aug 12

Cancer Cells That Survived Chemo Released a Common Sugar, and Their Neighbors Started Letting G

Wistar researchers found that fructose acts as a message between ovarian cancer cells, stripping the cholesterol that holds tumors together.

Medical Daily · Aug 12

Johnson & Johnson seeks to end decade-long talc litigation with $5.5 billion settlement

Johnson & Johnson has struck a substantial deal worth more than five billion dollars, aimed at settling numerous lawsuits that allege cancer linked to its talc products. Following an ineffective bankruptcy resolution attempt, this latest agreement will facilitate quicker claims disbursement while keeping the door open for others who develop…

The Economic Times · Jul 30

Johnson & Johnson Pays $5.5B Over Baby Powder Cancer Claims; Wall Street Rewards It Anyway

Johnson & Johnson's $5.5B talc settlement impacts ovarian cancer claims and stock performance. Learn about the legal outcomes, unresolved issues, and future implications for claimants and investors.

International Business Times UK · Jul 29

Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight

Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer

The Independent UK · Jul 28

J&J reaches sweeping talc product settlement

NEW YORK - ‌Johnson & Johnson has announced that it will pay an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a landmark deal that could end a contentious legal battle that has dogged the company…

Bangkok Post · Jul 28

Johnson & Johnson reaches $5.5 bn talc settlement that could end decade of litigation

Johnson & Johnson will pay an estimated $5.5 billion to resolve talc product lawsuits. This landmark deal covers approximately seventy-six thousand claims alleging cancer causation. The company previously settled most claims involving asbestos and mesothelioma litigation. Johnson & Johnson expects to pay $3 billion in 2027 and further payments in…

The Economic Times · Jul 28

Ads call ovarian cancer a ‘silent killer’. But does urging women to undergo early detection testing do more harm than good?

Website offering blood check is aimed at people with a higher risk of disease – and false positives can create fear

The Guardian - AU · Jul 21

Tennis legend Chris Evert says her ovarian cancer has returned: ‘It’s relentless, but I’ll stay optimistic’

The American, 71, is a former world No 1 and 18-time grand-slam champion

The Independent UK · Jun 25